The issue of who is to succeed Simon Michel in Marketing & Sales has been resolved internally. The two business segments, Injection Systems and Diabetes Care, will be managed separately: Ulrike Bauer will manage Injection Systems business as of July 1, 2014 and Dr. Eberhard Bauer will manage Diabetes Care. They will both represent their business segments within the Management Board of the Ypsomed Group. Ypsomed is thus opting for continuity and broad-based experience in order to successfully realise planned future growth.

distributed by